Cargando…
Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid‐19 pandemic: A UK dermatology tertiary centre experience
Retrospective review data from 183 patients with psoriasis and/or hidradenitis suppurativa from a UK tertiary dermatology centre, suggests biologic therapy does not confer a significant increased risk of contracting severe Covid‐19 in this cohort. This is in line with a growing body of evidence whic...
Autores principales: | Khan, S., Karponis, D., Wali, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236977/ https://www.ncbi.nlm.nih.gov/pubmed/34235510 http://dx.doi.org/10.1002/ski2.54 |
Ejemplares similares
-
Hidradenitis suppurativa and psoriasis: the odd couple
por: Macca, Laura, et al.
Publicado: (2023) -
Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Bertolotti, A., et al.
Publicado: (2021) -
Consensus on the treatment of hidradenitis suppurativa - Brazilian
Society of Dermatology
por: Magalhães, Renata Ferreira, et al.
Publicado: (2019) -
Hidradenitis suppurativa: Coexistence or dermatological extraintestinal manifestation of Crohn's disease?
por: Luporini, Rafael Luís, et al.
Publicado: (2023) -
Innate Immunity Protein Markers Are Significantly Elevated in Hidradenitis Suppurativa Skin Than in Psoriasis Vulgaris
por: Moon, Sujin, et al.
Publicado: (2022)